Recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer

被引：1
|
作者：
Koie, Takuya [1 ]
Ohyama, Chikara [1 ]
Imai, Atsushi [1 ]
Hatakeyama, Shingo [1 ]
Yoneyama, Takahiro [1 ]
Hashimoto, Yasuhiro [1 ]
机构：
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.374
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NEOADJUVANT CHEMOTHERAPY RESULTS IN SKELETAL MUSCLE INDEX DECLINE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Steinsiek, Nikki
    Acevedo, Ann Martinez
    Guimaraes, Alexander
    Achim, Virginie
    Jones, Paul
    Bash, Jasper
    Whitaker, Makena
    Amling, Christopher L.
    Cetnar, Jeremy
    Liu, Jen-Jane
    JOURNAL OF UROLOGY, 2018, 199 (04): : E531 - E531
  • [32] Cost-effectiveness analysis of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
    Stevenson, Scott M.
    Deibert, Chris M.
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [33] BLADDER-SPARING SURGERY (BSS) FOR MUSCLE-INVASIVE BLADDER CANCER (MIBC) AFTER COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NAC)
    Herr, Harry
    JOURNAL OF UROLOGY, 2020, 203 : E1084 - E1084
  • [34] ETIOLOGY OF TREATMENT DELAYS IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    El-Arabi, Ahmad
    Sherman, Garth
    Holzbeierlein, Jeffrey
    Lee, Eugene
    Wulff-Burchfield, Elizabeth
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1025 - E1026
  • [35] Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    El-Arabi, Ahmad M.
    Alam, Syed M.
    Sherman, Garth
    Parker, William P.
    Thompson, Jeffrey
    Holzbeierlein, Jeffrey M.
    Lee, Eugene K.
    Wulff-Burchfield, Elizabeth M.
    BLADDER CANCER, 2020, 6 (04) : 435 - 444
  • [36] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [37] Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction
    Strother, Marshall C.
    Kutikov, Alexander
    Epstein, Matthew
    Bochner, Emily
    Deng, Mengying
    Handorf, Elizabeth
    Lewis, Bianca
    Ghatalia, Pooja
    Greenberg, Richard E.
    Chen, David
    Viterbo, Rosalia
    Anari, Fern
    Smaldone, Marc C.
    Zibelman, Matthew R.
    Uzzo, Robert G.
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    BJU INTERNATIONAL, 2022, 129 (03) : 364 - 372
  • [38] Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer
    Sternberg, CN
    Parmar, MKB
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 21S - 27S
  • [39] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: A new standard of care?
    Harland, S
    BJU INTERNATIONAL, 2003, 92 (09) : 877 - 878
  • [40] Neoadjuvant chemotherapy in muscle-invasive bladder cancer: Ready for prime time?
    Pouessel, Damien
    Mongiat-Artus, Pierre
    Culine, Stephane
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 288 - 294
12345